Abstract:Objective: Comparative assessment of the level of differentiating growth factor 15 (GDF 15 ) against the background of a 6-month course of respiratory support in the mode of automatic positive pressure in the airways therapy (aPAP therapy) in patients with obstructive sleep apnea syndrome (OSA). Material and methods: 59 men participated in the study, the average age was 51.9±2.4 years. The main group (MG1) consisted of 30 patients with a verified diagnosis of moderate OSA. 29 men of comparable age and body weight made up the control group (CG) without an objectively confirmed diagnosis of OSA. After the stage of introduction into the study, the type of respiratory support with individual pressure settings was selected for patients with MG1. After 6 months of aPAP therapy with high compliance (at least 85%), the same patients who made up MG2 after treatment underwent repeated polysomnography (PSG) and the GDF 15 content was evaluated. Methods: questionnaire, examination, polysomnography, enzyme immunoassay of blood serum to determine the content of GDF 15. Results: A 6-month course of aPAP therapy with a high degree of compliance significantly improved the sleep structure and breathing pattern: the representation of NREM 3 increased from 79.2±15.6 to 102.6±21.6 minutes and the REM phase from 56.9± 13.6 to 115.6±26.8. Episodes of apnea were eliminated - apnea-hypopnea index decreased from 21.1 [17.3; 39.1] to 2.5 [1.8; 4.6] and the average values of SaO2 increased from 85.9% to 91.5%. At the same time, a statistically significant excess of GDF 15 was revealed in MG1 - 20.4 [14.16; 31.71] and MG2 - 17.2 [13.63; 24.44]) in comparison with CG - 13.65 [10.7; 17.09]. Despite the lack of statistical significance, a change in the level of GDF 15 was revealed in the form of a decrease in its concentration after a 6-month course of aPAP therapy. Conclusion: A 6-month course of aPAP therapy made it possible to eliminate intermittent nocturnal hypoxia and improve sleep structure in patients with OSA, as well as reduce the content of GDF 15 protein in blood serum in patients with OSA. However, the tendency to decrease the content of this protein, despite the lack of statistical reliability, confirms the effectiveness of OSA therapy and the possibility of preventing early and pathological aging from the standpoint of somnology and molecular biogerontology.

Changes in Genioglossus Muscle Activity in Obstructive Sleep Apnea Patients with and Without Snore Guard.

[The Change of Genioglossus Muscle Activity of OSAS Patients with and Without Snoreguard].

[The relationship between the changes of upper airway and genioglossus muscle activity after the treatment with Snoreguard].

The Relationship between the Efficiency of Snoreguard on OSAS and the Change of Genioglossus Muscle Activity

Characteristics of genioglossus neuromuscular activity in patients with obstructive sleep apnea during drug-induced sleep

Neuromuscular Properties of Genioglossus Activity in Healthy Adults and Obstructive Sleep Apnea Patients

The Effect of Genioglossus Activity to Velopharyngeal Surgery in Patient with Obstructive Sleep Apnea Hypopnea Syndrome

Effect of bite openings and mandibular protrusion on genioglossus muscle activity in healthy adults with oral appliance

The molecular pathology of genioglossus in obstructive sleep apnea

[Characteristic of Mandibular Muscle Activity in Patients with Obstructive Sleep Hypopnea Apnea Syndrome].

A mechanism for upper airway stability during slow wave sleep

The Combination of Anatomy and Physiology in Predicting the Outcomes of Velopharyngeal Surgery

[Changes the level of differentiating growth factor - GDF 15 in patients with sleep apnea syndrome after aPAP-therapy: pilot study]

Neural drive to human genioglossus in obstructive sleep apnoea

A Novel Design of an Oral Appliance for Monitoring Electromyograms of the Genioglossus Muscle in Obstructive Sleep Apnea Syndrome

[Clinical Effect and Airway Changes of Adjustable Oral Appliance in the Treatment of Adult Obstructive Sleep Apnea Hypopnea Syndrome].

Reorganization of Sleep Patterns after Genioglossus Advancement and Hyoid Suspension Plus Z-palatopharyngoplasty for Patients with Severe OSAHS

Volume change of upper airway induced by mandibular advancement device in patients with obstructive sleep apnea hypopnea syndrome and analysis of relevant factors

[Changes of Upper Airway Morphology Induced by Mandibular Advancement in Patients with Obstructive Sleep Apnea Syndrome].

Mechanisms underlying the prolonged activation of the genioglossus following arousal from sleep

Alterations of IGF-1, Complement C3 and Superoxide Dismutase in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome.